T-cell and B-cell Immunology
T-cell and B-cell Immunology is a research topic within Immunology. Science Explorer counts 82k research works in it since 1950. 24.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the development, function, and regulation of regulatory T cells (Tregs), particularly emphasizing the role of transcription factor Foxp3, TGF-ß induction, immune tolerance, thymic selection, memory T cells, IL-2 signaling, and their involvement in tumor immunity and immunological surveillance. The cluster also explores the implications of Tregs in autoimmunity and their potential for therapeutic interventions.
- Foxp3
- TGF-ß
- CD4+CD25+
- Immune Tolerance
- Autoimmunity
- Thymic Selection
- Memory T Cells
- IL-2
- Tumor Immunity
- Immunological Surveillance
- Research works
- 82k fractional, since 1950
- In the world top 10%
- 20k per year above
- Top-10% rate
- 24.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -9% the tick is no change
Which countries lead T-cell and B-cell Immunology research?
By volume, the United States and China publish the most (2.3k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.3k works
- 2 China 1.2k works
- 3 Germany 415 works
- 4 Japan 339 works
- 5 United Kingdom 324 works
- 6 France 323 works
- 7 Australia 162 works
- 8 Canada 157 works
- 9 Spain 156 works
- 10 Italy 154 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead T-cell and B-cell Immunology research?
By volume in 2022–2025, Harvard University publishes the most T-cell and B-cell Immunology research, followed by Inserm and University of Pennsylvania.
By volume, 2022–2025
- 1 Harvard University United States 47 works
- 2 Inserm France 42 works
- 3 University of Pennsylvania United States 40 works
- 4 Emory University United States 38 works
- 5 Stanford University United States 33 works
- 6 Blood Center of Zhejiang Province China 32 works
- 7 Washington University in St. Louis United States 31 works
- 8 Chinese Academy of Medical Sciences & Peking Union Medical College China 30 works
- 9 University of Pittsburgh United States 30 works
- 10 Karolinska Institutet Sweden 29 works
Who are the leading researchers in T-cell and B-cell Immunology?
The most-cited researchers publishing on T-cell and B-cell Immunology include Mostafa Qorbani, Paul I. W. de Bakker and Dirk Schadendorf.
- 1 Mostafa Qorbani 5.9k citations
- 2 Paul I. W. de Bakker 4.8k citations
- 3 Dirk Schadendorf 4.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is T-cell and B-cell Immunology research done?
The largest centres of T-cell and B-cell Immunology research in 2022–2025 are Beijing (China), Paris (France), London (United Kingdom) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Kirov, Hualien City and Bethesda.
Largest cities, 2022–2025
Where it is the local speciality
- KirovRU · 32.4 works67×
- Hualien CityTW · 20.4 works23×
- BethesdaUS · 93.5 works11×
- AuroraUS · 22.0 works7.9×
Location quotient: how much more of its research is in T-cell and B-cell Immunology than the world average.
Where is the best place to study T-cell and B-cell Immunology?
Among universities, judged by research, Karolinska Institutet, University of Colorado Anschutz Medical Campus and Harvard University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Karolinska Institutet Sweden | 60.2 | 24.1% | 9.8× | 29 | +12.4% |
| 2 | University of Colorado Anschutz Medical Campus United States | 58.4 | 18.9% | 10.8× | 20 | +168.2% |
| 3 | Harvard University United States | 55.2 | 36.8% | 5.5× | 47 | -30.1% |
| 4 | University of Pennsylvania United States | 50.6 | 30.0% | 6.4× | 40 | -29.4% |
| 5 | Washington University in St. Louis United States | 49.1 | 34.2% | 6.3× | 30 | -31.8% |
| 6 | Emory University United States | 48.8 | 15.7% | 8.1× | 38 | -11.2% |
| 7 | University of California, San Francisco United States | 48.0 | 33.4% | 6.0× | 26 | -6.4% |
| 8 | Stanford University United States | 47.5 | 36.9% | 4.0× | 32 | -3.7% |
| 9 | University of Pittsburgh United States | 45.1 | 24.9% | 5.8× | 30 | -0.5% |
| 10 | Medical University of Vienna Austria | 43.3 | 29.4% | 7.0× | 14 | -20.6% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is T-cell and B-cell Immunology research growing?
Output in 2018–2022 was 9% lower than in 2013–2017, peaking in 2009.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.